The effect of vitamin D replacement on patients with subclinical hypothyroidism

Phase 3

Recruiting

• Conditions: Subclinical iodine-deficiency hypothyroidism; Subclinical Hypothyroidism.

• Registration Number: IRCT20190610043856N1
• Lead Sponsor: Fasa University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 March 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 75

Inclusion Criteria

Subclinical Hypothyroidism
Vitamin D Deficiency

Exclusion Criteria

Vitamin D replacement therapy in the last 15 months
Overt hypothyroidism
Those taking medications that affect thyroid function such as steroid and L-thyroxine
Patients with symptoms of hypothyroid,
Cardiovascular risk factors,
Positive TPO antibody
Abnormal T4
Pregnant women
TSH >10 mIU/l

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Thyroid stimulating hormone (TSH) between 5 to 10 mU/L. Timepoint: Thyroid-stimulating hormone (TSH) measurement at baseline (before intervention) and 2 months after the intervention. Method of measurement: Enzyme Linked Fluorescence Assay.;Vitamin D deficiency. Timepoint: Vitamin D measurement at baseline (before intervention) and 2 months after the intervention. Method of measurement: Enzyme Linked Flourscience Assay.